Data: 08/08/2026
Total encontrado: 8
1/8US=337 / Tese/FAP
Faloppa CC. Análise Imunoistoquímica da expressão do NF-KB e da COX-2 em alterações proliferativas endometriais. [Immunohistochemical analysis of NF-&*954;B and the COX-2 expressions in endometrial proliferative lesions]. São Paulo, 2011. 107 p. Dissertação(Mestrado)-Fundação Antônio Prudente.

Disponível em: http://accamargo.phlnet.com.br/MESTRADO/2011/CarlosFalopa/CarlosFalopa.pdf

Curriculum Lattes

NEOPLASIAS DO ENDOMETRIO; HIPERPLASIA ENDOMETRIAL; IMUNOISTOQUIMICA; CICLOOXIGENASE-2; NF-KB; POLIPOS; TISSUE MICROARRAY

2/8US=85 / Biol/Mol
Plantivaux A, Szegezdi E, Samali A, Egan L. Is there a role for nuclear factor kB in tumor necrosis factor-related apoptosis-inducing ligand resistance?. In: Diederich M. Natural compounds and their role in apoptotic cell signaling pathways. Boston: Blackwell, 2009. p. 38-49. (Annals of the New York Academy of Sciences Vol 1171) ISBN 978-1-57331-737-5.

CANCER; APOPTOSE; RESISTENCIA; INIBIDORES DE PROTEASSOMA; SUPER-REPRESSOR; MTOR; TRAIL; NF-KB

3/8US=13 / Biol/Mol
Pecorino L. Infections and inflammation. In: ___. Molecular biology of cancer: mechanisms, targets, and therapeutics. 2nd ed. Oxford: Oxford University Press, 2008. p. 211-30. ISBN 978-0-19-921148-7.

INFECCAO; INFLAMACAO; VIRUS EPSTEIN-BARR; PAPILOMAVIRUS HUMANO (HPV); CELULAS T HUMANO TIPO 1; LEUCEMIA; VIRUS DA HEPATITE B; CANCER HEPATICO; CANCER DE FIGADO; SARCOMA DE KAPOSI; HERPESVIRUS; HELICOBACTER PYLORI; CANCER GASTRICO; NF-KB; VACINA

4/8US=39 / Câncer
Chatterjee D, Sabo E, Resnick MB, Yeung KC, Chin YE. The RKIP and STAT3 axis in cancer chemotherapy: opposites attract. In: Bonavida B. Sensitization of cancer cells for chemo/immuno/radio-therapy. Los Angeles: Humana Press, 2008. p. 159-74. ISBN 978-1-58829-989-5.

RKIP; STAT3; QUIMIOTERAPIA; CANCER; APOPTOSE; NF-KB; VIA JAK/STAT; RKIP

5/8US=86 / Biol/Mol
Fan Y, Dutta J, Gupta N, Fan G, Gélinas C. Regulation of programmed cell death by NF-kB and its role in tumorigenesis and therapy. In: Khosravi-Far R, White E. Programmed cell death in cancer progression and therapy. New York: Springer, 2008. p. 223-50. (Advances in Experimental Medicina and Biology, 615) ISBN 978-1-4020-6553-8.

REGULACAO DA MORTE CELULAR; NF-KB; TUMORIGENESE; TERAPIA; APOPTOSE; NECROSE; FATOR DE TRANSCRICAO; CANCER

6/8US=92 / Biol/Mol
Ricci MS, El-Deiry WS. Apoptosis and alternative modes of cell death: the extrinsic pathway of apoptosis. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 31-54. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9.

APOPTOSE; TNF; FAS; TRAIL; NF-KB; QUIMIOTERAPIA; RECEPTOR MORTE; RECEPTOR CHAMARIZ; VIA EXTRINSECA; AUTOIMUNIDADE

7/8US=47 / Clín/Medica
Labbozzetta M, Notarbartolo M, Poma P, Giannitrapani L, Cervello M, Montalto G, D'Alessandro N. Significance of autologous interleukin-6 production in the HA22T/VGH cell model of hepatocellular carcinoma. In: Bradlow KL, Carruba G. Estrogens and human diseases. Boston: Blackwell, 2006. p. 268-75. ISBN 978-1-57331-699-5.

CARCINOMA HEPATOCELULAR; INTERLEUCINA-6; CIRCUITO ESTIMULANTE DO CRESCIMENTO CELULAR AUTOCRINE; NF-KB

8/8US=47 / Clín/Medica
Yatrin E, Bernoulli J, Santti R. Activation of NF-kB in association with prostate carcinogenesis in noble rats. In: Bradlow KL, Carruba G. Estrogens and human diseases. Boston: Blackwell, 2006. p. 282-5. ISBN 978-1-57331-699-5.

INFLAMACAO; NF-KB; CARCINOGENESE DA PROSTATA